1959
1963
1969
1974
The Novo Foundation establishes a committee responsible for awarding grants for ”medicine and the related natural science fields”. Poul Iversen chairs the committee. This is the forerunner of the current committee structure of the Novo Nordisk Foundation.
The Novo Prize (now the Novo Nordisk Prize) is awarded for the first time. The Prize is awarded to recognize unique medical research or other research contributions that benefit medical science. The first recipient of the Prize is Erik Warburg.
The August Krogh Prize (now the Marie and August Krogh Prize) is awarded for the first time, and annually thereafter, to an outstanding health researcher in Denmark. The prize is awarded in collaboration with the Danish Medical Society (now the Organization of Danish Medical Societies).
In 1973, Novo Terapeutisk Laboratorium and Novo Industri (established in 1957) merge and become Novo Industri A/S, the internationally known name. In 1974, the company is listed on the Copenhagen Stock Exchange.
1985
Following several years of exploratory discussions about collaboration, the Novo Nordisk Foundation is created on 12 January with the merger of Nordisk Insulinlaboratorium, the Nordisk Insulin Foundation and the Novo Foundation. The two operating companies Nordisk Gentofte A/S and Novo Industri A/S also merge to become Novo Nordisk A/S.
NORDISK INSULINLABORATORIUM
NORDISK GENTOFTE
1957
1966
Niels Steensens Hospital (Steno Memorial Hospital) opens a new laboratory for carrying out research into the causes and progression of diabetes.
The Hagedorn Prize is awarded for the first time. The Prize is awarded in collaboration with the Danish Society for Internal Medicine to recognize excellent research or development efforts within internal medicine.
HAGEDORN RESEARCH LABORATORY
NIELS STEENSENS HOSPITAL
1979 Nordisk Insulinlaboratorium is reorganized into three divisions: 1) the commercial arm, Nordisk Gentofte A/S; 2) the research laboratory at Niels Steensens Hospital becomes independent and is renamed the Hagedorn Research Laboratory; and 3) Niels Steensens Hospital (Steno Memorial Hospital). The Nordisk Insulin Foundation continues to award grants.
Nordisk Gentofte A/S is listed on the Copenhagen stock exchange.
1984
1987 The Nordisk Insulin Foundation arranges the first in a series of scientific symposia under the title of the Nordic Insulin Symposium. The more informal Novo Nordisk Foundation Research Meetings replace the symposia in 1995.
T s o K s f p p r